ArticleJCO global oncology2020

ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol.

Atara I Ntekim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.